EMA News
🇪🇺 EMAEMA news and analysis for pharmaceutical BD, investment, and market access
Get critical EMA regulatory updates for drug approvals, clinical trials, and market access in Europe & UK. Stay ahead of pharma compliance.
Showing 1–12 of 69 articles
Quick answer
NovaPharmaNews EMA News hub for EMA covers 69 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
EMA board backs Ebola response, flags 2025 annual report at June meeting
EMA Tightens Liver Safety Checks for Tavneos After Fatal Cases
EMA researchers map AI research priorities across the medicines lifecycle
EMA approved 104 human medicines in 2025: what changed
EMA Post Authorisation Guidance Faces Evidence Gaps After 10 Years
EMA approves TX01 PIP, unlocking the PUMA pathway for Theranexus and Exeltis
World Lightproof Bottle Opaque Liners Market: Pharma Growth to 2035
New EU Template for Clinical Trial Recruitment and Informed Consent: What Pharma Teams Need to Know
India-Oman CEPA Fast-Tracks Drug Approvals, Cuts Export Barriers for Pharma
Moderna Stock Rises as EMA Committee Backs New RSV Vaccine: Key Implications for Investors and BD Teams
From Approval to Access: Europe’s Next Health Imperative for Pharma
Lilly to Spotlight Growing Hematology Portfolio at 2026 EHA Annual Meeting: Key Data and Strategic Implications
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.